CDRE insider filing: 4,132 shares proposed sale via UBS ($152.9K)

Rhea-AI Filing Summary

Cadre Holdings, Inc. (CDRE) filed a Form 144 reporting a proposed Rule 144 sale of common stock. The filing states a broker (UBS Financial Services, Inc., New York) is named to sell 4,132 shares with an aggregate market value of $152,884, representing a very small fraction of the issuer's reported 40,663,844 outstanding shares. The securities were acquired as restricted stock units (RSUs) on 03/09/2024 and 03/13/2024 and the filer reports no sales in the prior three months. The notice includes the standard attestation regarding material nonpublic information and Rule 10b5-1 plan language.

Insights

Securities Analyst

TL;DR: Insignificant insider sale in size; procedural disclosure indicates routine liquidity, not a material event.

The reported proposed sale of 4,132 shares for $152,884 is immaterial relative to 40.66 million shares outstanding (approx. 0.01%). The shares originated from recently vested RSUs dated March 9 and March 13, 2024, suggesting the transaction is for personal liquidity rather than disposition of long-held shares. The use of a major broker and the Form 144 filing show regulatory compliance. This disclosure alone is unlikely to affect CDRE’s valuation or signal operational changes.

Corporate Governance Expert

TL;DR: Filing meets disclosure obligations; no governance red flags from this single, small sale.

The notice contains the required representations about nonpublic material information and references potential Rule 10b5-1 plan timing. The acquisition source listed as the issuer (RSUs) and the absence of prior three-month sales reduce concerns about coordinated insider liquidations. From a governance perspective, this is routine insider activity with proper documentation; it does not indicate management turnover or governance deterioration.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	4132	152884.00	40663844	09/23/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/13/2024	RSU	Issuer			2541	03/13/2024	N/A
Common	03/09/2024	RSU	Issuer			1591	03/09/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Cadre Holdings (CDRE) report on this Form 144?

The filing reports a proposed sale of 4,132 common shares through UBS Financial Services with an aggregate market value of $152,884.

How large is the proposed sale relative to Cadre's outstanding shares?

The filing lists 40,663,844 shares outstanding; 4,132 shares are approximately 0.01% of outstanding shares.

When were the shares acquired that are being sold?

The securities were acquired as RSUs on 03/09/2024 (1,591 shares) and 03/13/2024 (2,541 shares).

Does the filing indicate prior sales by the filer in the last three months?

No. The section for securities sold during the past three months states Nothing to Report.

Who is acting as broker for the sale?

The broker named is UBS Financial Services, Inc., 11 Madison Ave, 4th Floor, New York, NY and the sale is to occur on the NYSE approximately on 09/23/2025.